4C
4C9.F CVS Group plc
- Market cap
- EUR 1.09B
- P/E
- 58.2x
- P/B
- 3.09x
- ROE
- 6.1%
- Dividend yield
- 0.67%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 4C9.F undervalued?
Graham number4C9.F trades 182.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CVS Group plc fundamental analysis
No fundamental analysis for CVS Group plc yet.
CVS Group plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CVS Group plc
CVS Group plc, together with its subsidiaries, engages in veterinary practices, online pharmacy, veterinary diagnostic, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescr…
Full company profileCVS Group plc financial statements
CVS Group plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 218M | 272M | 327M | 407M | 428M | 510M | 554M | 608M | 639M | 713M |
| Gross Profit | 106M | 125M | 152M | 169M | 170M | 222M | 239M | 262M | 269M | 316M |
| Operating Income | 11.8M | 17.2M | 17.7M | 15.6M | 18.5M | 40.1M | 42.8M | 62.3M | 47.8M | 47.6M |
| EBITDA | - | 38.7M | 43.7M | 46.5M | 63.9M | 87.8M | 90.0M | 118M | 105M | 113M |
| Net Income | 7.00M | 11.5M | 10.7M | 8.20M | 5.70M | 19.3M | 25.7M | 41.9M | 6.40M | 17.8M |
| EPS | - | 0.18 | 0.15 | 0.12 | 0.08 | 0.27 | 0.36 | 0.59 | 0.09 | 0.26 |
| Balance Sheet | ||||||||||
| Total Assets | 206M | 263M | 319M | 377M | 464M | 485M | 518M | 572M | 690M | 768M |
| Total Liabilities | 160M | 175M | 161M | 214M | 298M | 293M | 301M | 315M | 430M | 472M |
| Shareholders' Equity | 46.6M | 88.0M | 158M | 163M | 167M | 191M | 217M | 257M | 260M | 290M |
| Cash & Short-term Investments | 6.70M | 6.80M | 15.0M | 12.5M | 21.5M | 33.7M | 49.0M | 21.5M | 16.5M | 18.4M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 27.9M | 29.7M | 37.4M | 41.4M | 77.6M | 60.2M | 75.5M | 84.5M | 67.8M | 71.3M |
| Capital Expenditure | 11.5M | 13.3M | 10.2M | 11.9M | 11.1M | 16.1M | 23.0M | 42.3M | 43.1M | 36.4M |
| Free Cash Flow | - | 15.9M | 26.7M | 28.5M | 65.2M | 43.6M | 51.0M | 38.8M | 24.7M | 34.9M |
| Ratios | ||||||||||
| ROE | 15.0% | 13.1% | 6.8% | 5.0% | 3.4% | 10.1% | 11.8% | 16.3% | 2.5% | 6.1% |
| ROA | 3.4% | 4.4% | 3.4% | 2.2% | 1.2% | 4.0% | 5.0% | 7.3% | 0.9% | 2.3% |
| Net Profit Margin | 3.2% | 4.2% | 3.3% | 2.0% | 1.3% | 3.8% | 4.6% | 6.9% | 1.0% | 2.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CVS Group plc dividends
- Dividend yield
- 0.67%
- Forward dividend
- 0.11 EUR
- Payout ratio
- 34.3%
- Ex-dividend date
- Nov 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 6.10M | 0.09 | 34.3% |
| 2025 | - | - | - |
| 2024 | GBP 5.40M | 0.08 | 84.4% |
| 2023 | GBP 5.00M | 0.07 | 11.9% |
| 2022 | GBP 4.60M | 0.06 | 17.9% |
| 2021 | GBP 4.60M | 0.07 | 23.8% |
| 2020 | EUR 3.90M | 0.06 | 68.4% |
| 2019 | EUR 3.50M | 0.05 | 42.7% |
| 2018 | EUR 2.90M | 0.04 | 27.1% |
| 2017 | EUR 2.10M | 0.03 | 18.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CVS Group plc
- Insiders 0.75%
- Institutions 86.46%
- Public & others 12.80%
- Shares outstanding 66.6M
- Free float 68.0M
CVS Group plc company profile
- Company name
- CVS Group plc
- Ticker
- 4C9.F
- ISIN
- GB00B2863827
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Diversified Consumer Services
- Employees
- 9,000
- Fiscal year end
- June
- Address
- CVS House, Diss, United Kingdom, IP22 4ER
- Phone
- 44 137 9644288
- Website
- cvsukltd.co.uk
About CVS Group plc
CVS Group plc, together with its subsidiaries, engages in veterinary practices, online pharmacy, veterinary diagnostic, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, health supplements, pet foods, and pet accessories; pet clubs; and laboratories, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom.
CVS Group plc management
10- Mr. Richard William Mark Fairman F.C.A.CEO & Director · born 1967
- Mr. Robin Jay Alfonso F.C.A.CFO & Director · born 1979
- Mr. Paul Stephen HiggsChief Veterinary Officer & Director · born 1982
- Charlotte PageGroup Financial Controller & Head of Investor Relations
- Mr. Scott MorrisonGroup General Counsel & Company Secretary · born 1970
- Ms. Helen FinneyChief People Officer
- Mr. Gordon PalmerHead of IT
- James CahillMVB - Managing Director of CVS International
- Ben AveryManaging Director of CVS Vets Australia
- Ms. Elizabeth McLennan-GreenSmall Animal Veterinary Director